Vimpat 100mg tablets have been recalled by Medicines and Healthcare products Regulatory Agency

We have been informed by the Medicines and Healthcare products Regulatory Agency (MHRA) that they are supporting a precautionary recall for Vimpat 100mg tablets.

This medicine has been imported into the UK from Italy and has been re-labelled.

The medicine is believed to be legitimate, but was taken out of the regulated medicines' supply chain during distribution and was later re-introduced. This means that the correct transport and storage conditions cannot be guaranteed during this period. Whilst unlikely, this could impact its effectiveness.

There is no evidence that Vimpat was tampered with. This means that the risk of the medicine not being fully effective is greatly reduced.  

If you are currently taking Vimpat, the MHRA advises that you should continue taking your medicine and contact your GP practice to arrange a new prescription. Once you have a new prescription, you should return the affected batches to your pharmacist.

The following batch numbers of Vimpat are affected:

This recall has happened because in the very unlikely event that these products are not fully effective, there is a potential risk to patient safety. For these medicines, whilst their effectiveness being compromised is low, the consequences from a lack of effectiveness could be serious which is why they are being recalled.

More information:

Please refer to the MHRA alert for further information on the batches affected.

If you have any queries about the recall, please email info@mhra.gov.uk